We are live on
!
Find out more
OMS
Obvious Management Services Portfolio holdings
AUM
$42.4M
1-Year Est. Return
54.5%
This Fund
S&P 500
This Quarter
Est. Return
-26.75%
1 Year Est. Return
-54.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$118M
AUM Growth
–
Cap. Flow
+$132M
Cap. Flow
% of AUM
112.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Recursion Pharmaceuticals
RXRX
|
+$112M |
| 2 |
LILM
Lilium N.V. Class A Ordinary Shares
LILM
|
+$14.7M |
| 3 |
Planet Labs
PL
|
+$4.73M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.1% |
| 2 | Industrials | 12.9% |
Similar funds
NR
SCM
AM
PSCM
ER
HLC
ATGP
LCM
Obvious Management Services's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Obvious Management Services, which disclosed 3 positions worth $118M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Recursion Pharmaceuticals: 5,977,631 shares worth $102M.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets, followed by Industrials.
- Obvious Management Services's largest Q4 2021 buy was Recursion Pharmaceuticals: 5,977,631 shares worth $102M.
- Obvious Management Services's ten largest holdings make up 100% of its $118M portfolio in Q4 2021.
- Obvious Management Services disclosed 3 positions in Q4 2021, its first 13F filing on record.
Based on Obvious Management Services's 13F filing for Q4 2021, filed 14 Feb 2022.